JavaScript is disabled for your browser. Some features of this site may not work without it.
  • About K
  • Academics
  • Admission
  • Alumni Relations
  • Giving to K
  • News & Events
  • Student Life
  • HORNET HIVE
  • ATHLETICS
  • SITEMAP
  • WEBMAIL
    • Login
    View Item 
    •   CACHE Homepage
    • Academic Departments, Programs, and SIPs
    • Biology
    • Biology Senior Integrated Projects
    • View Item
    •   CACHE Homepage
    • Academic Departments, Programs, and SIPs
    • Biology
    • Biology Senior Integrated Projects
    • View Item

    Selective myostatin inhibitor - P AH-A: effects of in ovo administration on skeletal muscle development in chickens

    Thumbnail
    View/Open
    Searchable PDF / Kalamazoo College Only (2.488Mb)
    Date
    2007
    Author
    Snider, Brittany A.
    Metadata
    Show full item record
    Abstract
    The commercial meat industry is a valuable component of the United States economy, and scientists have spent decades investigating methods for improving muscle production in agricultural animals. A breakthrough in the exploration of muscle development occurred in 1997 with the identificat ion of myostatin, a negative regulator of skeletal muscle growth (McPherron et ai, 1997). Inhibition of myostatin through genetic alteration, the use of monoclonal anti-myostatin antibodies, and treatments of a soluble form of the activin type II receptor protein are effective methods for increasing muscle production in mice and poultry. The purpose of our study was to investigate effects of Pfizer Animal Health-Compound A (PAH-A), a selective myostatin inhibitor, on skeletal muscle production in broiler chickens. We hypothesized that in ova administration of PAH-A would favorably increase muscle development by means of hypertrophy. We analyzed mean body mass gain (BMG) and cross-sectional area (CSA) of broiler pectoralis major samples nine treatments groups on post-hatch days 3 (D3) and 14 (DI4). Our results revealed a positive correlation between the CSA and body mass (BM) of control birds (R = 0.96) and showed significant differences (p < 0.05) in mean CSA between D3 and DI4 tissue samples. Our results did not support our hypothesis because we failed to observe significant differences in BMG or CSA between control and PAH-A groups. Additional studies are required for accurate evaluation of PAH-A as a myostatin inhibitor. In addition to improvements in agricultural meat production, future applications of PAH-A and other myostatin inhibitors could become successful methods for reversing the effects of muscle degenerative diseases in humans.
    URI
    http://hdl.handle.net/10920/24335
    Collections
    • Biology Senior Integrated Projects [1615]

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    DSpace software copyright © 2002-2022  DuraSpace
    DSpace Express is a service operated by 
    Atmire NV
    Logo

    Kalamazoo College
    1200 Academy Street
    Kalamazoo Michigan 49006-3295
    USA
    Info 269-337-7000
    Admission 1-800-253-3602

    About K
    Academics
    Admission
    Alumni Relations
    Giving to K
    News & Events
    Student Life
    Sitemap
    Map & Directions
    Contacts
    Directories
    Nondiscrimination Policy
    Consumer Information
    Official disclaimer
    Search this site


    Academic Calendars
    Apply
    Bookstore
    Crisis Response
    Employment
    Library
    Registrar
    DSpace Express is a service operated by 
    Atmire NV